|
|
|
|
|
|
UNITED STATES |
|
|
|
SECURITIES AND EXCHANGE COMMISSION |
|
|
|
Washington, D.C. 20549 |
|
|
|
|
|
SCHEDULE 13G/A
Under
the Securities Exchange Act of 1934
Amendment No. 1
SUCAMPO PHARMACEUTICALS, INC.
(Name of Issuer)
CLASS A COMMON STOCK
(Title of Class of Securities)
864909106
(CUSIP Number)
DECEMBER 31, 2009
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
o |
Rule 13d-1(b) |
|
o |
Rule 13d-1(c) |
|
x |
Rule 13d-1(d) |
Check the following box if a fee is being paid with this statement. o
|
CUSIP No.: 864909106 |
|||||
|
|
|||||
|
|
(1) |
Name of Reporting Person S&R TECHNOLOGY HOLDINGS, LLC 52-2242847 |
|||
|
|
|||||
|
|
(2) |
Check the Appropriate Box if a Member of a Group |
|||
|
|
|
(a) |
o |
||
|
|
|
(b) |
o |
||
|
|
|||||
|
|
(3) |
SEC Use Only |
|||
|
|
|||||
|
|
(4) |
Citizenship |
|||
|
|
|
|
|||
|
Number of |
(5) |
Sole Voting Power |
|||
|
|
|||||
|
(6) |
Shared Voting Power |
||||
|
|
|||||
|
(7) |
Sole Dispositive Power |
||||
|
|
|||||
|
(8) |
Shared Dispositive Power |
||||
|
|
|||||
|
|
(9) |
Aggregate Amount
Beneficially Owned by Each Reporting Person |
|||
|
|
|||||
|
|
(10) |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares o |
|||
|
|
|||||
|
|
(11) |
Percent of Class
Represented by Amount in Row (9) |
|||
|
|
|||||
|
|
(12) |
Type of Reporting Person |
|||
(1) Includes 26,191,050 shares of Class B Common Stock of the issuer. Each share of Class B Common Stock is convertible at any time into one share of Class A Common Stock without further consideration. Also includes 2,485,150 shares of Class A Common Stock owned by R-Tech Ueno, Ltd. (“R-Tech”). S&R Technology Holdings, LLC is R-Tech’s largest shareholder, owning 16,370 shares, or 33.26%, of R-Tech’s capital stock as of the date of this filing. R-Tech acquired these shares before the initial public offering of Sucampo Pharmaceuticals, Inc. Voting and dispositive power with respect to the shares owned by R-Tech is held by its board of directors. S&R disclaims beneficial ownership of these shares.
|
Item 1(a). |
Name of Issuer |
|
|
Item 1(b). |
Address of Issuer’s
Principal Executive Offices SUITE 300 BETHESDA, MD 20814 |
|
|
|
||
|
Item 2(a). |
Name of Person Filing |
|
|
Item 2(b). |
Address of Principal
Business Office or, if none, Residence SUITE 600 BETHESDA, MD 20814-6519 |
|
|
Item 2(c). |
Citizenship |
|
|
Item 2(d). |
Title of Class of
Securities |
|
|
Item 2(e). |
CUSIP No. |
|
|
|
||
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
NOT APPLICABLE |
|
(2) Sucampo Pharmaceuticals, Inc. (the “Issuer”) is the successor to Sucampo Pharma Americas, Inc., a Delaware corporation formerly named Sucampo Pharmaceuticals, Inc., for purposes of filings under Section 13(d) of the Securities Exchange Act of 1934, as amended, as a result of a reorganization into a holding company structure. In the reorganization the Issuer became the new parent holding company of Sucampo Pharma Americas, Inc.
|
Item 4. |
Ownership |
||
|
|
(a) |
Amount beneficially owned: 29,785,952(3) |
|
|
|
(b) |
Percent of class: 71.2% |
|
|
|
(c) |
Number of shares as to which the person has:
|
|
|
|
|
(i) |
Sole power to vote or to direct the vote: 29,785,952(3) |
|
|
|
(ii) |
Shared power to vote or to direct the vote: 0 |
|
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 29,785,952(3) |
|
|
|
(iv) |
Shared power to dispose or to direct the disposition of: 0 |
|
|
|||
|
Item 5. |
Ownership of Five Percent or Less of a Class |
||
|
|
NOT APPLICABLE |
||
|
|
|||
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
||
|
|
NOT APPLICABLE |
||
|
|
|||
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
||
|
|
NOT APPLICABLE |
||
|
|
|||
|
Item 8. |
Identification and Classification of Members of the Group |
||
|
|
NOT APPLICABLE |
||
|
|
|||
|
Item 9. |
Notice of Dissolution of Group |
||
|
|
NOT APPLICABLE |
||
|
|
|||
(3) See footnote 1 on the cover page to this schedule.
|
Item 10. |
Certifications |
|
|
NOT APPLICABLE |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
Dated: February 16, 2010 |
S&R TECHNOLOGY HOLDINGS, LLC |
|
|
|
|
|
|
|
By: |
/s/ Sachiko Kuno |
|
|
Name: |
Sachiko Kuno |